Mark R. Stroud

2.0k total citations
28 papers, 1.6k citations indexed

About

Mark R. Stroud is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Mark R. Stroud has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Organic Chemistry and 6 papers in Immunology. Recurrent topics in Mark R. Stroud's work include Glycosylation and Glycoproteins Research (19 papers), Carbohydrate Chemistry and Synthesis (9 papers) and Cell Adhesion Molecules Research (5 papers). Mark R. Stroud is often cited by papers focused on Glycosylation and Glycoproteins Research (19 papers), Carbohydrate Chemistry and Synthesis (9 papers) and Cell Adhesion Molecules Research (5 papers). Mark R. Stroud collaborates with scholars based in United States, Denmark and Sweden. Mark R. Stroud's co-authors include Sen‐itiroh Hakomori, Kazuko Handa, James M. Olson, Stacey Hansen, Steven B. Levery, Henrik Clausen, Mary Ellen K. Salyan, Tatsushi Toyokuni, Bruce A. Fenderson and S Hakomori and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Biochemistry.

In The Last Decade

Mark R. Stroud

28 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Stroud United States 21 1.1k 355 277 220 200 28 1.6k
Marko Fonovič Slovenia 24 1.5k 1.4× 203 0.6× 590 2.1× 164 0.7× 176 0.9× 49 2.7k
Raj Parekh United Kingdom 23 1.7k 1.6× 399 1.1× 495 1.8× 82 0.4× 433 2.2× 30 2.2k
Wolfgang Kemmner Germany 24 1.7k 1.6× 714 2.0× 181 0.7× 206 0.9× 192 1.0× 63 2.5k
Michael Etzerodt Denmark 30 1.6k 1.5× 512 1.4× 66 0.2× 205 0.9× 141 0.7× 69 2.8k
Annemarie C. Lellouch France 17 729 0.7× 523 1.5× 189 0.7× 82 0.4× 313 1.6× 28 1.2k
Christine Galustian United Kingdom 25 1.3k 1.2× 719 2.0× 444 1.6× 68 0.3× 243 1.2× 61 2.2k
Thomas Kjeldsen Denmark 29 2.3k 2.1× 572 1.6× 280 1.0× 102 0.5× 592 3.0× 57 3.0k
Jason E. Hudak United States 11 1.1k 1.1× 303 0.9× 477 1.7× 178 0.8× 239 1.2× 16 1.6k
Veronica Morea Italy 29 1.8k 1.7× 265 0.7× 65 0.2× 125 0.6× 498 2.5× 72 2.5k
C. Chandra Kumar United States 24 1.8k 1.6× 218 0.6× 153 0.6× 46 0.2× 144 0.7× 43 2.5k

Countries citing papers authored by Mark R. Stroud

Since Specialization
Citations

This map shows the geographic impact of Mark R. Stroud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Stroud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Stroud more than expected).

Fields of papers citing papers by Mark R. Stroud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Stroud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Stroud. The network helps show where Mark R. Stroud may publish in the future.

Co-authorship network of co-authors of Mark R. Stroud

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Stroud. A scholar is included among the top collaborators of Mark R. Stroud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Stroud. Mark R. Stroud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fidel, Janean L., William S. Dernell, Stacey Hansen, et al.. (2015). Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors. Cancer Research. 75(20). 4283–4291. 61 indexed citations
2.
Stroud, Mark R., Stacey Hansen, & James M. Olson. (2011). In Vivo Bio-imaging Using Chlorotoxin-based Conjugates. Current Pharmaceutical Design. 17(38). 4362–4371. 67 indexed citations
3.
Akcan, Muharrem, Mark R. Stroud, Stacey Hansen, et al.. (2011). Chemical Re-engineering of Chlorotoxin Improves Bioconjugation Properties for Tumor Imaging and Targeted Therapy. Journal of Medicinal Chemistry. 54(3). 782–787. 78 indexed citations
4.
Veiseh, Mandana, S-Bahram Bahrami, Miqin Zhang, et al.. (2007). Tumor Paint: A Chlorotoxin:Cy5.5 Bioconjugate for Intraoperative Visualization of Cancer Foci. Cancer Research. 67(14). 6882–6888. 350 indexed citations
5.
Olsson, Martin L., Humberto de la Vega, Qiyong Liu, et al.. (2004). Universal red blood cells—enzymatic conversion of blood group A and B antigens. Transfusion Clinique et Biologique. 11(1). 33–39. 56 indexed citations
6.
Schwientek, Tilo, Steven B. Levery, Mads A. Jensen, et al.. (2002). The Drosophila Gene brainiac Encodes a Glycosyltransferase Putatively Involved in Glycosphingolipid Synthesis. Journal of Biological Chemistry. 277(36). 32421–32429. 49 indexed citations
7.
Davis, William C., et al.. (2000). A GDP-Fucose-Protected, Pyridoxal-5′-Phosphate/NaBH4-Sensitive Lys Residue Common to Human α1→3Fucosyltransferases Corresponds to Lys300 in FucT-IV. Biochemical and Biophysical Research Communications. 273(3). 870–876. 8 indexed citations
8.
Steffensen, Rudi, Joëlle Wiels, Steven B. Levery, et al.. (2000). Cloning and Expression of the Histo-blood Group PkUDP-galactose:Galβ1–4Glcβ1-Cer α1,4-Galactosyltransferase. Journal of Biological Chemistry. 275(22). 16723–16729. 90 indexed citations
9.
Macher, Bruce A., et al.. (1998). Human α1,3/4-Fucosyltransferases. Journal of Biological Chemistry. 273(39). 25256–25260. 25 indexed citations
10.
Stroud, Mark R. & Eric H. Holmes. (1997). Fucosylation of Complex Glycosphingolipids by Recombinant Fucosyltransferase-VII. Biochemical and Biophysical Research Communications. 238(1). 165–168. 12 indexed citations
11.
14.
Zhu, Mengjin, et al.. (1995). Monoclonal Antibody Directed to Ley Oligosaccharide Inhibits Implantation in the Mouse1. Biology of Reproduction. 52(4). 903–912. 66 indexed citations
16.
Kojima, Naoya, Bruce A. Fenderson, Mark R. Stroud, et al.. (1994). Further studies on cell adhesion based on Lex-Lex interaction, with new approaches: embryoglycan aggregation of F9 teratocarcinoma cells, and adhesion of various tumour cells based on Lex expression. Glycoconjugate Journal. 11(3). 238–248. 106 indexed citations
17.
Stroud, Mark R., Steven B. Levery, Mary Ellen K. Salyan, Carl E. Roberts, & Sen‐itiroh Hakomori. (1992). Extended type‐1 chain glycosphingolipid antigens. European Journal of Biochemistry. 203(3). 577–586. 22 indexed citations
18.
Levery, Steven B., Mary Ellen K. Salyan, Mark R. Stroud, et al.. (1992). Structural characterization of x2 glycosphingolipid, its extended form, and its sialosyl derivatives: accumulation associated with the rare blood group p phenotype. Biochemistry. 31(28). 6509–6517. 24 indexed citations
19.
Salyan, Mary Ellen K., Mark R. Stroud, Thomas A. Baillie, & Steven B. Levery. (1991). Differentiation of type 1 and type 2 chain linkages of native glycosphingolipids by positive‐ion fast‐atom bombardment mass spectrometry with collision‐induced dissociation and linked scanning. Rapid Communications in Mass Spectrometry. 5(10). 456–462. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026